MORRISTOWN, N.J.–(Company WIRE)–Melinta Therapeutics, LLC (“Melinta”), a industrial-stage organization giving progressive therapies for acute and lifestyle-threatening sicknesses, announces the appointment of Susan Blum as Main
Tag: Melinta
Melinta Therapeutics Announces Appointment of Susan Blum as Main Financial Officer
MORRISTOWN, N.J., June 29, 2021–(Enterprise WIRE)–Melinta Therapeutics, LLC (“Melinta”), a business-phase business delivering ground breaking therapies for acute and existence-threatening ailments, announces the appointment of